Finberg RW, Diamond DC, Mitchell DB, et al. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120. Science. 1990;249(4966):287-91.
Moore JP, Simpson G, McKeating JA, Burakoff SJ, Schreiber SL, Weiss RA. CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro. Virology. 1992;188(2):537-44.
Zhou G, Ferrer M, Chopra R, et al. The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core. Bioorg Med Chem. 2000;8(9):2219-27.
Burgener A, Rahman S, Ahmad R, et al. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J Proteome Res. 2011;10(11):5139-49. doi:10.1021/pr200596r
Matheson NJ, Sumner J, Wals K, et al. Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef. Cell Host Microbe. 2015;18(4):409-23. doi:10.1016/j.chom.2015.09.003
Tas JMJ, Mesin L, Pasqual G, et al. Visualizing antibody affinity maturation in germinal centers. Science. 2016;351(6277):1048-54. doi:10.1126/science.aad3439
Kløverpris HN, Kazer SW, Mjösberg J, et al. Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. Immunity. 2016;44(2):391-405. doi:10.1016/j.immuni.2016.01.006
McLaren PJ, Coulonges C, Bartha I, et al. Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci U S A. 2015;112(47):14658-63. doi:10.1073/pnas.1514867112
Ozkumur AY, Goods BA, Love C. Development of a High-Throughput Functional Screen Using Nanowell-Assisted Cell Patterning. Small. 2015;11(36):4643-50. doi:10.1002/smll.201500674
Barton KM, Archin NM, Keedy KS, et al. Selective HDAC inhibition for the disruption of latent HIV-1 infection. PLoS One. 2014;9(8):e102684. doi:10.1371/journal.pone.0102684